Evidence map›Paper›PMID 38887527›Full record

ArticleBeilstein journal of nanotechnology2024

Radiofrequency enhances drug release from responsive nanoflowers for hepatocellular carcinoma therapy.

Yanyan Wen, Ningning Song, Yueyou Peng, Weiwei Wu, Qixiong Lin, Minjie Cui, Rongrong Li, Qiufeng Yu, Sixue Wu, Yongkang Liang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Beilstein journal of nanotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yanyan WenSchool of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Ningning SongCollege of Medical Imaging, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Yueyou PengDepartment of Radiology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China.
Weiwei WuSchool of Public Health, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Qixiong LinThe Ninth Clinical Medical School of Shanxi Medical University, Taiyuan, Shanxi 030009, China.
Minjie CuiCollege of Medical Imaging, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Rongrong LiCollege of Medical Imaging, Shanxi Medical University, Taiyuan, Shanxi, 030001, China.
Qiufeng YuDepartment of Radiology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China.
Sixue WuAcademy of Medical Sciences, Shanxi Medical University, Taiyuan, Shanxi 030001, China.
Yongkang LiangDepartment of Radiology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China.
Wei TianDepartment of General Surgery, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi 030024, China.ORCID https://orcid.org/0000-0003-2398-5968
Yanfeng MengDepartment of Radiology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, Shanxi 030009, China.ORCID https://orcid.org/0000-0002-4992-1631

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the sixth most common malignant tumor and the third leading cause of cancer death worldwide. Most patients are diagnosed at an advanced stage, and systemic chemotherapy is the preferred treatment modality for advanced HCC. Curcumin (CUR) is a polyphenolic antineoplastic drug with low toxicity obtained from plants. However, its low bioavailability and poor solubility limit its functionality. In this study, radiofrequency- (RF) enhanced responsive nanoflowers (NFs), containing superparamagnetic ferric oxide nanoclusters (Fe

Indexed as

curcuminhepatocellular carcinomamagnetic resonance imaging (MRI)radiofrequency (RF) hyperthermiaresponsive nanoflower

Identifiers

PMID38887527
PMCPMC11181167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.